Ikena Oncology’s $143.8 Million IPO

Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal.Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”), a targeted oncology company focused on developing cancer therapies…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now